Zoetis Shares Outstanding 2012-2025 | ZTS

Zoetis shares outstanding history from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Zoetis shares outstanding for the quarter ending September 30, 2025 were 0.443B, a 2.27% decline year-over-year.
Zoetis 2024 shares outstanding were 0.455B, a 1.61% decline from 2023.
Zoetis 2023 shares outstanding were 0.462B, a 1.73% decline from 2022.
Zoetis 2022 shares outstanding were 0.47B, a 1.33% decline from 2021.

Zoetis Annual Shares Outstanding (Millions of Shares)
2024	455
2023	462
2022	470
2021	477
2020	479
2019	482
2018	487
2017	493
2016	498
2015	502
2014	502
2013	500
2012	500
2011	500

Zoetis Quarterly Shares Outstanding (Millions of Shares)
2025-09-30	443
2025-06-30	446
2025-03-31	448
2024-12-31	455
2024-09-30	454
2024-06-30	456
2024-03-31	459
2023-12-31	462
2023-09-30	461
2023-06-30	463
2023-03-31	465
2022-12-31	470
2022-09-30	469
2022-06-30	472
2022-03-31	474
2021-12-31	477
2021-09-30	476
2021-06-30	477
2021-03-31	478
2020-12-31	479
2020-09-30	479
2020-06-30	478
2020-03-31	479
2019-12-31	482
2019-09-30	482
2019-06-30	482
2019-03-31	483
2018-12-31	487
2018-09-30	486
2018-06-30	488
2018-03-31	490
2017-12-31	493
2017-09-30	492
2017-06-30	494
2017-03-31	495
2016-12-31	498
2016-09-30	498
2016-06-30	499
2016-03-31	500
2015-12-31	502
2015-09-30	502
2015-06-30	500
2015-03-31	503
2014-12-31	502
2014-09-30	502
2014-06-30	502
2014-03-31	501
2013-12-31	500
2013-09-30	500
2013-06-30	500
2013-03-31	500
2012-12-31	500
2012-09-30	500
2012-06-30	500
2012-03-31	500
2011-12-31

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$54.668B	$9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$91.260B	34.66
Takeda Pharmaceutical (TAK)	Japan	$51.834B	10.58
Daiichi Sankyo, - (DSNKY)	Japan	$37.584B	18.72
BeOne Medicines - (ONC)	Switzerland	$37.211B	197.28
Sandoz Group AG (SDZNY)	Switzerland	$35.741B	0.00
United Therapeutics (UTHR)	United States	$20.191B	17.77
Merck (MKKGY)	Germany	$19.464B	12.00
Shionogi (SGIOY)	Japan	$16.929B	15.55
IPSEN (IPSEY)	France	$13.608B	0.00
Neurocrine Biosciences (NBIX)	United States	$13.578B	32.58
Ionis Pharmaceuticals (IONS)	United States	$13.004B	0.00
Summit Therapeutics (SMMT)	United States	$12.716B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$10.912B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.411B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.967B	21.19
Stevanato Group S.p.A (STVN)	Italy	$5.230B	29.27
Crinetics Pharmaceuticals (CRNX)	United States	$5.046B	0.00
Corcept Therapeutics (CORT)	United States	$4.626B	49.98
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.547B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.209B	19.99
Indivior (INDV)	United States	$4.122B	16.82
NewAmsterdam Pharma (NAMS)	Netherlands	$3.778B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.397B	0.00
Hypermarcas (HYPMY)	Brazil	$2.977B	20.43
Catalyst Pharmaceuticals (CPRX)	United States	$2.898B	9.25
Dyne Therapeutics (DYN)	United States	$2.571B	0.00
Soleno Therapeutics (SLNO)	United States	$2.275B	0.00
Ocular Therapeutix (OCUL)	United States	$2.188B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.932B	37.21
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.916B	22.70
Ardelyx (ARDX)	United States	$1.888B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.731B	0.00
Oruka Therapeutics (ORKA)	United States	$1.665B	0.00
Harrow (HROW)	United States	$1.647B	101.07
Enliven Therapeutics (ELVN)	United States	$1.530B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.438B	7.12
BioCryst Pharmaceuticals (BCRX)	United States	$1.431B	84.88
Relay Therapeutics (RLAY)	United States	$1.288B	0.00
Evotec AG (EVO)	Germany	$1.282B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.234B	0.00
Savara (SVRA)	United States	$1.225B	0.00
Aktis Oncology (AKTS)	United States	$1.097B	0.00
Cronos Group (CRON)	Canada	$1.061B	0.00
Theravance Biopharma (TBPH)	United States	$1.026B	43.06
ARS Pharmaceuticals (SPRY)	United States	$1.009B	0.00
Xencor (XNCR)	United States	$0.913B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.851B	20.12
KalVista Pharmaceuticals (KALV)	United States	$0.810B	0.00
Nektar Therapeutics (NKTR)	United States	$0.755B	0.00
Esperion Therapeutics (ESPR)	United States	$0.751B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.671B	5.99
Bioventus (BVS)	United States	$0.664B	13.59
ProKidney (PROK)	United States	$0.653B	0.00
Altimmune (ALT)	United States	$0.574B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.547B	0.00
Lyell Immunopharma (LYEL)	United States	$0.537B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.505B	0.00
Organogenesis (ORGO)	United States	$0.498B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.488B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.487B	0.00
Siga Technologies (SIGA)	United States	$0.476B	6.51
4D Molecular Therapeutics (FDMT)	United States	$0.455B	0.00
Nature's Sunshine Products (NATR)	United States	$0.432B	25.70
USANA Health Sciences (USNA)	United States	$0.412B	11.49
Aquestive Therapeutics (AQST)	United States	$0.395B	0.00
Cybin (HELP)	Canada	$0.376B	0.00
Akebia Therapeutics (AKBA)	United States	$0.361B	0.00
Protara Therapeutics (TARA)	United States	$0.320B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.312B	0.00
Larimar Therapeutics (LRMR)	United States	$0.305B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.298B	0.00
Avalo Therapeutics (AVTX)	United States	$0.292B	0.00
Profound Medical (PROF)	Canada	$0.289B	0.00
Fractyl Health (GUTS)	United States	$0.286B	0.00
Relmada Therapeutics (RLMD)	United States	$0.286B	0.00
OmniAb (OABI)	United States	$0.282B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.268B	0.00
Heron Therapeutics (HRTX)	United States	$0.260B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.256B	0.00
Journey Medical (DERM)	United States	$0.236B	0.00
MediWound (MDWD)	Israel	$0.227B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.223B	0.00
Galectin Therapeutics (GALT)	United States	$0.213B	0.00
Century Therapeutics (IPSC)	United States	$0.212B	0.00
AleAnna (ANNA)	United States	$0.192B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Minerva Neurosciences (NERV)	United States	$0.172B	0.00
Surrozen (SRZN)	United States	$0.168B	0.00
Context Therapeutics (CNTX)	United States	$0.166B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
VAXART, INC (VXRT)	United States	$0.161B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.153B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.149B	0.00
Avita Medical (RCEL)	United States	$0.135B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.131B	0.00
Prelude Therapeutics (PRLD)	United States	$0.127B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.121B	0.00
Incannex Healthcare (IXHL)	Australia	$0.119B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.119B	0.00
Vivani Medical (VANI)	United States	$0.108B	0.00
Cassava Sciences (SAVA)	United States	$0.106B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.104B	0.00
Pyxis Oncology (PYXS)	United States	$0.101B	0.00
Korro Bio (KRRO)	United States	$0.101B	0.00
Champions Oncology (CSBR)	United States	$0.094B	39.71
Gain Therapeutics (GANX)	United States	$0.079B	0.00
PolyPid (PYPD)	Israel	$0.076B	0.00
Assertio Holdings (ASRT)	United States	$0.074B	0.00
Dominari Holdings (DOMH)	United States	$0.068B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.065B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.064B	0.00
Metagenomi Therapeutics (MGX)	United States	$0.063B	0.00
Rafael Holdings (RFL)	United States	$0.063B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.062B	0.00
Arch Biopartners (ACHFF)	Canada	$0.061B	0.00
Lipocine (LPCN)	United States	$0.061B	0.00
ElectroCore (ECOR)	United States	$0.060B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.059B	49.13
Nutriband (NTRB)	United States	$0.058B	0.00
Lite Strategy (LITS)	United States	$0.047B	0.00
Talphera (TLPH)	United States	$0.047B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Plus Therapeutics (PSTV)	United States	$0.038B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.038B	0.00
Wellgistics Health (WGRX)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.035B	0.00
SCYNEXIS (SCYX)	United States	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.031B	0.00
TherapeuticsMD (TXMD)	United States	$0.030B	0.00
Natural Alternatives (NAII)	United States	$0.026B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Scienture Holdings (SCNX)	United States	$0.021B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.019B	0.00
Traws Pharma (TRAW)	United States	$0.019B	0.02
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Inotiv (NOTV)	United States	$0.019B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vivos Therapeutics (VVOS)	United States	$0.017B	0.00
Tempest Therapeutics (TPST)	United States	$0.015B	0.00
Mannatech (MTEX)	United States	$0.015B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Nuvilex (PMCB)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Mangoceuticals (MGRX)	United States	$0.008B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.005B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00